Accession PRJCA013937
Title PRP19 enhances esophageal squamous cell carcinoma progression by reprogramming SREBF1-dependent fatty acid metabolism
Relevance Medical
Data types lipidomics
Organisms Homo sapiens
Description Lipid metabolism reprogramming is a recognized hallmark of cancer cells. Identification of the underlying regulators of metabolic reprogramming in esophageal squamous cell carcinoma (ESCC) could uncover potential therapeutic targets to improve treatment. Here, we demonstrated that pre-mRNA processing factor 19 (PRP19) mediates reprogramming of lipid metabolism in ESCC. Expression of PRP19 was significantly upregulated in multiple ESCC cohorts and was correlated with poor clinical prognosis. PRP19 promoted ESCC proliferation in vitro and in vivo. Upregulation of PRP19 enhanced fatty acid synthesis through sterol regulatory element-binding protein 1 (SREBF1), a major transcription factor of lipid synthase. Moreover, PRP19 enhanced the stability of SREBF1 mRNA in an N6-methyladenosine dependent manner. Overall, this study shows that PRP19-mediated fatty acid metabolism is crucial for ESCC progression. Targeting PRP19 is a potential therapeutic approach to reverse metabolic reprogramming in ESCC patients.
Sample scope Monoisolate
Release date 2022-12-18
Grants
Agency program Grant ID Grant title
National Natural Science Foundation of China (NSFC) General Program 81970505
Submitter Guang-Cong Zhang (20111210054@fudan.edu.cn)
Organization zhongshan hospital of fudan
Submission date 2022-12-18

Project Data

Resource name Description